Volume 9, Issue 2 (May 2024)
JNFS 2024, 9(2): 214-222 |
Back to browse issues page
Esmaeil Yousefi Rad 
, Parivash Kavei , Soheila Akbari , Farhad Vahid , James R Hebert , Ebrahim Falahi , Mehdi Birjandi , Somayeh Saboori *
, Parivash Kavei , Soheila Akbari , Farhad Vahid , James R Hebert , Ebrahim Falahi , Mehdi Birjandi , Somayeh Saboori *
Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
Abstract: (846 Views)
Background: Polycystic ovary syndrome (PCOS) is an inflammation-related condition and a common metabolic disorder in women at fertility ages. The Dietary Inflammatory Index (DII) is a validated nutritional tool for estimating the inflammatory potential of the diet. It is assumed that a high DII score (indicating a predominantly inflammatory diet) has an association with higher odds of PCOS. The current study aimed to investigate the association between DII and PCOS risk in women. Methods: This case-control study was conducted in 2019-2020 on 120 newly-diagnosed PCOS cases and 120 healthy controls aged 18-45 years in Khorramabad, Iran. DII was estimated based on a validated 168-item Food Frequency Questionnaire (FFQ). Results: The mean±SD of DII in PCOS patients was 0.40±2.09, while it was 0.45±1.92 in the control group (P<0.001). There was a positive association between increasing DII score and the risk of PCOS (odds ratio= 2.41; 95%CI: 1.15-5.02, P for trend =0.006) in the crude model as the fourth quartile was compared with the lowest one. This association was still significant in several models after adjusting for age and energy intake (P for trend <0.001), in the model adjusted for the physical activity level, education status, and family history of PCOS (P for trend=0.003), and also after additional adjustment for BMI (P for trend= 0.003). Conclusions: The present study revealed that consuming more pro-inflammatory diets with higher DII scores is related to an increased risk of PCOS.
Keywords: Insulin resistance, Polycystic ovary syndrome, Metabolic diseases, Dietary inflammatory index.
Type of article: orginal article |
Subject:
public specific
Received: 2022/06/20 | Published: 2024/05/21 | ePublished: 2024/05/21
Received: 2022/06/20 | Published: 2024/05/21 | ePublished: 2024/05/21
References
1. Beydoun HA, et al. 2009. Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies. Reproductive biomedicine online. 18 (6): 856-863.
2. Bu Z, et al. 2012. The relationship between polycystic ovary syndrome, glucose tolerance status and serum preptin level. Reproductive biology and endocrinology. 10 (1): 10.
3. Chen G, et al. 2011. Cardiovascular disease (CVD) risk, insulin resistance and β-cell function in prehypertension population of China. Atherosclerosis. 217 (1): 279-285.
4. Cowey S & Hardy RW 2006. The metabolic syndrome: a high-risk state for cancer? American journal of pathology. 169 (5): 1505-1522.
5. Deepika ML, et al. 2013. TNF-α haplotype association with polycystic ovary syndrome - a South Indian study. Journal of assisted reproduction and genetics. 30 (11): 1493-1503.
6. Denova-Gutiérrez E, et al. 2018. Dietary inflammatory index and type 2 diabetes mellitus in adults: the diabetes mellitus survey of Mexico City. Nutrients. 10 (4): 385.
7. Fingert SB, Shah B, Kessler M, Pawelczak M & David R 2009. Evaluation of adolescents for polycystic ovary syndrome in an urban population. Journal of clinical research in pediatric endocrinology. 1 (4): 188.
8. Franks S 2006. Diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. Journal of clinical endocrinology & metabolism. 91 (3): 786-789.
9. Gluszak O, et al. 2012. Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN endocrinology. 2012.
10. González F 2012. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 77 (4): 300-305.
11. González F, Rote NS, Minium J & Kirwan JP 2006. Increased activation of nuclear factor κB triggers inflammation and insulin resistance in polycystic ovary syndrome. Journal of clinical endocrinology & metabolism. 91 (4): 1508-1512.
12. Goodarzi MO, et al. 2012. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. Journal of medical genetics. 49 (2): 90-95.
13. Kaya C, et al. 2010. Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome. Fertility and sterility. 94 (4): 1437-1443.
14. Kim H-Y, Lee J & Kim J 2018. Association between dietary inflammatory index and metabolic syndrome in the general Korean population. Nutrients. 10 (5): 648.
15. Lujan ME, Chizen DR & Pierson RA 2008. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. Journal of obstetrics and gynaecology Canada. 30 (8): 671-679.
16. Meier RK 2018. Polycystic ovary syndrome. Nursing Clinics. 53 (3): 407-420.
17. Merkin SS, et al. 2011. Socioeconomic status and polycystic ovary syndrome. Journal of women's health. 20 (3): 413-419.
18. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M & Azizi F 2010. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public health nutrition. 13 (5): 654-662.
19. Moghaddam MB, et al. 2012. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World applied sciences journal. 18 (8): 1073-1080.
20. Moran C, Arriaga M, Rodriguez G & Moran S 2012. Obesity differentially affects phenotypes of polycystic ovary syndrome. International journal of endocrinology. 2012: 1-7.
21. Neufcourt L, et al. 2015. Prospective association between the dietary inflammatory index and metabolic syndrome: Findings from the SU. VI. MAX study. Nutrition, metabolism and cardiovascular diseases. 25 (11): 988-996.
22. Neufcourt L, et al. 2016. Prospective association between the dietary inflammatory index and cardiovascular diseases in the SUpplémentation en VItamines et Minéraux AntioXydants (SU. VI. MAX) cohort. Journal of the American Heart Association. 5 (3): e002735.
23. Pastore LM, Patrie JT, Morris WL, Dalal P & Bray MJ 2011. Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women. Journal of psychosomatic research. 71 (4): 270-276.
24. Repaci A, Gambineri A & Pasquali R 2011. The role of low-grade inflammation in the polycystic ovary syndrome. Molecular and cellular endocrinology. 335 (1): 30-41.
25. Rosenfield RL & Ehrmann DA 2016. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine reviews. 37 (5): 467-520.
26. Rudnicka E, et al. 2021. Chronic low grade inflammation in pathogenesis of PCOS. International journal of molecular sciences. 22 (7): 3789.
27. Ruiz-Canela M, et al. 2015. Dietary inflammatory index and anthropometric measures of obesity in a population sample at high cardiovascular risk from the PREDIMED (PREvencion con DIeta MEDiterranea) trial. British journal of nutrition. 113 (6): 984-995.
28. Saboori S, et al. 2016. Various effects of omega 3 and omega 3 plus vitamin E supplementations on serum glucose level and insulin resistance in patients with coronary artery disease. Iranian journal of public health. 45 (11): 1465.
29. Saboori S, Rad EY, Birjandi M, Mohiti S & Falahi E 2019. Serum insulin level, HOMA-IR and prostate cancer risk: A systematic review and meta-analysis. Diabetes & metabolic syndrome: Clinical research & reviews. 13 (1): 110-115.
30. Sayehmiri F, Kiani F, Maleki F, Ahmadi M & Shohani M 2014. Prevalence of polycystic ovary syndrome in Iranian women: a systematic review and meta-analysis. Iranian journal of obstetrics, gynecology and infertility. 17 (115): 11-21.
31. Schwingshackl L & Hoffmann G 2014. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutrition, metabolism and cardiovascular diseases. 24 (9): 929-939.
32. Shivappa N, et al. 2015. Association between dietary inflammatory index and prostate cancer among Italian men. British journal of nutrition. 113 (2): 278-283.
33. Shivappa N, et al. 2014. A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS). Public health nutrition. 17 (8): 1825-1833.
34. Shoelson SE, Lee J & Goldfine AB 2006. Inflammation and insulin resistance. Journal of clinical investigation. 116 (7): 1793-1801.
35. Tabung FK, et al. 2015. Construct validation of the dietary inflammatory index among postmenopausal women. Annals of epidemiology. 25 (6): 398-405.
36. Tehrani FR, Rashidi H & Azizi F 2011. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reproductive biology and endocrinology. 9 (1): 144.
37. Vahid F, Rahmani D & Davoodi SH 2020. Validation of Dietary Antioxidant Index (DAI) and investigating the relationship between DAI and the odds of gastric cancer. Nutrition & metabolism. 17 (1): 102.
38. Vasheghani-Farahani A, et al. 2011. The Persian, last 7-day, long form of the International Physical Activity Questionnaire: translation and validation study. Asian journal of sports medicine. 2 (2): 106.
39. Vatandoost A, Azadbakht L, Morvaridi M, Kabir A & Farsani GM 2020. Association between dietary inflammatory index and risk of cardiovascular diseases among firefighters. International journal of preventive medicine. 11 (1): 133.
40. Vázquez-Carballo A, et al. 2013. TWEAK prevents TNF-α-induced insulin resistance through PP2A activation in human adipocytes. American journal of physiology-endocrinology and metabolism. 305 (1): E101-E112.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |